{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T22:26:48Z","timestamp":1782944808390,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Reversible cerebral vasoconstriction syndrome (RCVS) has a heterogenous clinical and radiological presentation. We investigated whether RCVS complications vary according to age.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods<\/jats:title><jats:p>In a pooled French cohort of 345 patients with RCVS, we assessed (1) rates of clinical and radiological complications, and (2) the functional outcome at 3\u00a0months according to age as a continuous variable, and in young patients aged\u2009\u2264\u200949\u00a0years versus those aged\u2009\u2265\u200950\u00a0years. The<jats:italic>Commission Nationale Informatique et Libert\u00e9<\/jats:italic>and the local ethics committee approved this study (registration number: 202100733).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The risk for any focal deficit and for any brain lesion were independently associated with increasing age (OR 1.4, 95% CI 1.1\u20131.8;<jats:italic>p<\/jats:italic>\u2009=\u20090.014, and OR 1.6, 95% CI 1.2\u20132.1;<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, respectively). Subtypes of brain lesions independently associated with increasing age were subarachnoid haemorrhage (OR 1.7, 95% CI 1.3\u20132.3;<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and intracerebral haemorrhage (OR 1.5, 95% CI 1.1\u20132.2;<jats:italic>p<\/jats:italic>\u2009=\u20090.023). Frequency of cervical artery dissections peaked at age 30\u201339, and young age was independently associated with cervical artery dissections (OR 13.6, 95% CI 2.4\u201376.6;<jats:italic>p<\/jats:italic>\u2009=\u20090.003). Age had no impact on the functional outcome, with a modified Rankin scale score of 0\u20131 in\u2009&gt;\u200996% of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Age seems to influence rates and types of complications of RCVS, with young age being associated with cervical artery dissections, and increasing age with haemorrhagic complications. If confirmed in larger prospective studies, recognition of age-specific patterns might help to guide clinical management and to identify complications in cases of RCVS and vice versa.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s00415-023-11708-z","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T11:04:48Z","timestamp":1681383888000},"page":"3584-3594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Complications of reversible cerebral vasoconstriction syndrome in relation to age"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8056-8514","authenticated-orcid":false,"given":"Kristin Sophie","family":"Lange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Tuloup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Duflos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Gobron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cilia","family":"Burcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ducros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Mawet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"11708_CR1","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S1474-4422(12)70135-7","volume":"11","author":"A Ducros","year":"2012","unstructured":"Ducros A (2012) Reversible cerebral vasoconstriction syndrome. Lancet Neurol 11:906\u2013917","journal-title":"Lancet Neurol"},{"key":"11708_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7326\/0003-4819-146-1-200701020-00007","volume":"146","author":"LH Calabrese","year":"2007","unstructured":"Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB (2007) Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 146:34\u201344","journal-title":"Ann Intern Med"},{"key":"11708_CR3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1177\/0333102414566197","volume":"35","author":"A Sanchez-Montanez","year":"2015","unstructured":"Sanchez-Montanez A, Morana G, Mancardi MM et al (2015) Reversible cerebral vasoconstriction mimicking posterior reversible encephalopathy syndrome in an infant with end-stage renal disease. Cephalalgia 35:1031\u20131033","journal-title":"Cephalalgia"},{"key":"11708_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1177\/0883073817696817","volume":"32","author":"SW Coffino","year":"2017","unstructured":"Coffino SW, Fryer RH (2017) Reversible cerebral vasoconstriction syndrome in pediatrics: a case series and review. J Child Neurol 32:614\u2013623","journal-title":"J Child Neurol"},{"key":"11708_CR5","doi-asserted-by":"publisher","first-page":"e1468","DOI":"10.1212\/WNL.0000000000006367","volume":"91","author":"H de Boysson","year":"2018","unstructured":"de Boysson H, Parienti JJ, Mawet J et al (2018) Primary angiitis of the CNS and reversible cerebral vasoconstriction syndrome: a comparative study. Neurology 91:e1468\u2013e1478","journal-title":"Neurology"},{"key":"11708_CR6","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1161\/STROKEAHA.121.034424","volume":"52","author":"SD Patel","year":"2021","unstructured":"Patel SD, Topiwala K, Otite Oliver F et al (2021) Outcomes among patients with reversible cerebral vasoconstriction syndrome: a nationwide United States analysis. Stroke 52:3970\u20133977","journal-title":"Stroke"},{"key":"11708_CR7","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/archneurol.2011.68","volume":"68","author":"AB Singhal","year":"2011","unstructured":"Singhal AB, Hajj-Ali RA, Topcuoglu MA et al (2011) Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 68:1005\u20131012","journal-title":"Arch Neurol"},{"key":"11708_CR8","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1177\/0333102419849013","volume":"39","author":"F Caria","year":"2019","unstructured":"Caria F, Zedde M, Gamba M et al (2019) The clinical spectrum of reversible cerebral vasoconstriction syndrome: The Italian Project on Stroke at Young Age (IPSYS). Cephalalgia 39:1267\u20131276","journal-title":"Cephalalgia"},{"key":"11708_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/ene.15064","volume":"29","author":"KS Lange","year":"2022","unstructured":"Lange KS, Forster O, Mawet J et al (2022) Type of headache at onset and risk for complications in reversible cerebral vasoconstriction syndrome. Eur J Neurol 29:130\u2013137","journal-title":"Eur J Neurol"},{"key":"11708_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1177\/0333102417715223","volume":"38","author":"HA Choi","year":"2018","unstructured":"Choi HA, Lee MJ, Choi H, Chung CS (2018) Characteristics and demographics of reversible cerebral vasoconstriction syndrome: a large prospective series of Korean patients. Cephalalgia 38:765\u2013775","journal-title":"Cephalalgia"},{"key":"11708_CR11","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1212\/WNL.0000000000001473","volume":"84","author":"SP Chen","year":"2015","unstructured":"Chen SP, Fuh JL, Lirng JF, Wang YF, Wang SJ (2015) Recurrence of reversible cerebral vasoconstriction syndrome: a long-term follow-up study. Neurology 84:1552\u20131558","journal-title":"Neurology"},{"key":"11708_CR12","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1177\/0333102418762471","volume":"38","author":"M Shimoda","year":"2018","unstructured":"Shimoda M, Oda S, Shigematsu H et al (2018) Clinical significance of centripetal propagation of vasoconstriction in patients with reversible cerebral vasoconstriction syndrome: a retrospective case\u2013control study. Cephalalgia 38:1864\u20131875","journal-title":"Cephalalgia"},{"key":"11708_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00415-022-11425-z","volume":"270","author":"DK Erhart","year":"2023","unstructured":"Erhart DK, Ludolph AC, Althaus K (2023) RCVS: by clinicians for clinicians\u2014a narrative review. J Neurol 270:673\u2013688","journal-title":"J Neurol"},{"key":"11708_CR14","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00415-014-7499-0","volume":"261","author":"D Wilson","year":"2014","unstructured":"Wilson D, Marshall CR, Solbach T, Watkins L, Werring DJ (2014) Intraventricular hemorrhage in reversible cerebral vasoconstriction syndrome. J Neurol 261:2221\u20132224","journal-title":"J Neurol"},{"key":"11708_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1212\/WNL.0000000000003510","volume":"88","author":"AB Singhal","year":"2017","unstructured":"Singhal AB, Topcuoglu MA (2017) Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. Neurology 88:228\u2013236","journal-title":"Neurology"},{"key":"11708_CR16","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00415-020-10193-y","volume":"268","author":"SD Patel","year":"2021","unstructured":"Patel SD, Topiwala K, Saini V et al (2021) Hemorrhagic reversible cerebral vasoconstriction syndrome: a retrospective observational study. J Neurol 268:632\u2013639","journal-title":"J Neurol"},{"key":"11708_CR17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/STROKEAHA.119.027703","volume":"51","author":"R Boitet","year":"2020","unstructured":"Boitet R, de Gaalon S, Duflos C et al (2020) Long-term outcomes after reversible cerebral vasoconstriction syndrome. Stroke 51:670\u2013673","journal-title":"Stroke"},{"key":"11708_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629\u2013808","journal-title":"Cephalalgia"},{"key":"11708_CR19","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00415-008-0796-8","volume":"255","author":"N Weisscher","year":"2008","unstructured":"Weisscher N, Vermeulen M, Roos YB, de Haan RJ (2008) What should be defined as good outcome in stroke trials; a modified Rankin score of 0\u20131 or 0\u20132? J Neurol 255:867\u2013874","journal-title":"J Neurol"},{"key":"11708_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/0885-3924(93)90107-7","volume":"8","author":"SD Silberstein","year":"1993","unstructured":"Silberstein SD, Merriam GR (1993) Sex hormones and headache. J Pain Symptom Manage 8:98\u2013114","journal-title":"J Pain Symptom Manage"},{"key":"11708_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.549038","volume":"11","author":"L Al-Hassany","year":"2020","unstructured":"Al-Hassany L, Haas J, Piccininni M, Kurth T, Maassen Van Den Brink A, Rohmann JL (2020) Giving researchers a headache\u2014sex and gender differences in migraine. Front Neurol 11:549038","journal-title":"Front Neurol"},{"key":"11708_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/2396987316656981","volume":"1","author":"MA Topcuoglu","year":"2016","unstructured":"Topcuoglu MA, McKee KE, Singhal AB (2016) Gender and hormonal influences in reversible cerebral vasoconstriction syndrome. Eur Stroke J 1:199\u2013204","journal-title":"Eur Stroke J"},{"key":"11708_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jamaneurol.2013.4639","volume":"71","author":"BS Katz","year":"2014","unstructured":"Katz BS, Fugate JE, Ameriso SF et al (2014) Clinical worsening in reversible cerebral vasoconstriction syndrome. JAMA Neurol 71:68\u201373","journal-title":"JAMA Neurol"},{"key":"11708_CR24","doi-asserted-by":"publisher","first-page":"S1237","DOI":"10.1016\/j.ajog.2020.09.037","volume":"226","author":"M FishelBartal","year":"2022","unstructured":"FishelBartal M, Sibai BM (2022) Eclampsia in the 21st century. Am J Obstet Gynecol 226:S1237-s1253","journal-title":"Am J Obstet Gynecol"},{"key":"11708_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s12028-009-9221-0","volume":"11","author":"JJ Fletcher","year":"2009","unstructured":"Fletcher JJ, Kramer AH, Bleck TP, Solenski NJ (2009) Overlapping features of eclampsia and postpartum angiopathy. Neurocrit Care 11:199\u2013209","journal-title":"Neurocrit Care"},{"key":"11708_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12929-022-00857-4","volume":"29","author":"SP Chen","year":"2022","unstructured":"Chen SP, Wang SJ (2022) Pathophysiology of reversible cerebral vasoconstriction syndrome. J Biomed Sci 29:72","journal-title":"J Biomed Sci"},{"issue":"Suppl 1","key":"11708_CR27","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.accpm.2016.06.010","volume":"35","author":"AG Aya","year":"2016","unstructured":"Aya AG, Ondze B, Ripart J, Cuvillon P (2016) Seizures in the peripartum period: epidemiology, diagnosis and management. Anaesth Crit Care Pain Med 35(Suppl 1):S13-s21","journal-title":"Anaesth Crit Care Pain Med"},{"key":"11708_CR28","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1161\/STROKEAHA.116.013136","volume":"47","author":"MA Topcuoglu","year":"2016","unstructured":"Topcuoglu MA, Singhal AB (2016) Hemorrhagic reversible cerebral vasoconstriction syndrome: features and mechanisms. Stroke 47:1742\u20131747","journal-title":"Stroke"},{"key":"11708_CR29","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1161\/STROKEAHA.109.572313","volume":"41","author":"A Ducros","year":"2010","unstructured":"Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG (2010) Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke 41:2505\u20132511","journal-title":"Stroke"},{"key":"11708_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/pgmj.2005.036053","volume":"82","author":"B Jani","year":"2006","unstructured":"Jani B, Rajkumar C (2006) Ageing and vascular ageing. Postgrad Med J 82:357\u2013362","journal-title":"Postgrad Med J"},{"key":"11708_CR31","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1161\/01.STR.0000080678.09344.8D","volume":"34","author":"MJ Ariesen","year":"2003","unstructured":"Ariesen MJ, Claus SP, Rinkel GJ, Algra A (2003) Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 34:2060\u20132065","journal-title":"Stroke"},{"key":"11708_CR32","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1161\/CIRCULATIONAHA.104.483628","volume":"111","author":"K Sutton-Tyrrell","year":"2005","unstructured":"Sutton-Tyrrell K, Najjar SS, Boudreau RM et al (2005) Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 111:3384\u20133390","journal-title":"Circulation"},{"key":"11708_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.hlc.2020.07.016","volume":"30","author":"M Acampa","year":"2021","unstructured":"Acampa M, Bongiorno M, Lazzerini PE et al (2021) Increased arterial stiffness is a predictor of delayed ischaemic stroke after subarachnoid haemorrhage. Heart Lung Circ 30:525\u2013530","journal-title":"Heart Lung Circ"},{"key":"11708_CR34","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1007\/s00415-021-10456-2","volume":"268","author":"A Garg","year":"2021","unstructured":"Garg A, Starr M, Rocha M, Ortega-Gutierrez S (2021) Predictors and outcomes of ischemic stroke in reversible cerebral vasoconstriction syndrome. J Neurol 268:3020\u20133025","journal-title":"J Neurol"},{"key":"11708_CR35","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1212\/WNL.0b013e3182a2cbe2","volume":"81","author":"J Mawet","year":"2013","unstructured":"Mawet J, Boukobza M, Franc J et al (2013) Reversible cerebral vasoconstriction syndrome and cervical artery dissection in 20 patients. Neurology 81:821\u2013824","journal-title":"Neurology"},{"key":"11708_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/head.12798","volume":"56","author":"J Mawet","year":"2016","unstructured":"Mawet J, Debette S, Bousser MG, Ducros A (2016) the link between migraine, reversible cerebral vasoconstriction syndrome and cervical artery dissection. Headache 56:645\u2013656","journal-title":"Headache"},{"key":"11708_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0333102416637826","volume":"37","author":"MA Topcuoglu","year":"2017","unstructured":"Topcuoglu MA, Kursun O, Singhal AB (2017) Coexisting vascular lesions in reversible cerebral vasoconstriction syndrome. Cephalalgia 37:29\u201335","journal-title":"Cephalalgia"},{"key":"11708_CR38","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1212\/WNL.0b013e31822f03fc","volume":"77","author":"S Debette","year":"2011","unstructured":"Debette S, Grond-Ginsbach C, Bodenant M et al (2011) Differential features of carotid and vertebral artery dissections: the CADISP study. Neurology 77:1174\u20131181","journal-title":"Neurology"},{"key":"11708_CR39","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S1474-4422(09)70084-5","volume":"8","author":"S Debette","year":"2009","unstructured":"Debette S, Leys D (2009) Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol 8:668\u2013678","journal-title":"Lancet Neurol"},{"key":"11708_CR40","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.110.000125","volume":"123","author":"S Debette","year":"2011","unstructured":"Debette S, Metso T, Pezzini A et al (2011) Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults. Circulation 123:1537\u20131544","journal-title":"Circulation"},{"key":"11708_CR41","doi-asserted-by":"publisher","first-page":"e639","DOI":"10.1212\/WNL.0000000000006917","volume":"92","author":"EA Rocha","year":"2019","unstructured":"Rocha EA, Topcuoglu MA, Silva GS, Singhal AB (2019) RCVS(2) score and diagnostic approach for reversible cerebral vasoconstriction syndrome. Neurology 92:e639\u2013e647","journal-title":"Neurology"},{"key":"11708_CR42","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.21951","volume":"67","author":"SP Chen","year":"2010","unstructured":"Chen SP, Fuh JL, Wang SJ et al (2010) Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes. Ann Neurol 67:648\u2013656","journal-title":"Ann Neurol"},{"key":"11708_CR43","volume":"13","author":"KB Dakay","year":"2021","unstructured":"Dakay KB, Azher I, Mahta A, Furie K, Yaghi S, Cutting SM (2021) Multifocal atraumatic convexity subarachnoid hemorrhage. Cureus 13:e16091","journal-title":"Cureus"},{"key":"11708_CR44","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1212\/WNL.0b013e3181d55efa","volume":"74","author":"S Kumar","year":"2010","unstructured":"Kumar S, Goddeau RP Jr, Selim MH et al (2010) Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology 74:893\u2013899","journal-title":"Neurology"},{"key":"11708_CR45","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1093\/brain\/awl105","volume":"129","author":"P Quinette","year":"2006","unstructured":"Quinette P, Guillery-Girard B, Dayan J et al (2006) What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain 129:1640\u20131658","journal-title":"Brain"},{"key":"11708_CR46","first-page":"3519","volume":"25","author":"TJ Song","year":"2021","unstructured":"Song TJ, Lee KH, Li H et al (2021) Reversible cerebral vasoconstriction syndrome: a comprehensive systematic review. Eur Rev Med Pharmacol Sci 25:3519\u20133529","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11708-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11708-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11708-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T17:02:15Z","timestamp":1702227735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11708-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["11708"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11708-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"7 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KSL received travel and accommodation expenses from Acticor Biotech and Teva, not related to the submitted work. CR received honoraria for board membership and speaker fees Allergan\/Abbvie, Homeperf, Lilly, Lundbeck, Mylan, Novartis, Ophtalmic, Orkyn, Pfizer, Sanofi and Teva, and travel, accommodation, and meeting expenses from Teva, Lundbeck and Lilly, all outside the submitted work. AD received honoraria for board membership and speaker fees from Allergan Abbvie, Lilly, Teva, Lundbeck, Pfizer and travel, accommodation, and meeting expenses from Teva, and SOS Oxyg\u00e8ne, all outside the submitted work; she is associate editor of Cephalalgia. JM received travel, accommodation, and meeting expenses from SOS, GEP Sante, Lundbeck and Homeperf and received honoraria for advisory boards or speaker fees from Abbvie, Teva, Lilly, Lundbeck and Novartis not related to the submitted work; he is a member of the redaction committee of \u201cLa Lettre du Neurologue\u201d without financial compensation. The other authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Verbal informed consent was obtained from the prospectively recruited patients for their anonymized information to be published. Informed consent was waived for the retrospectively included patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The <i>Commission Nationale Informatique et Libert\u00e9<\/i> and the local ethics committee of the University Hospital Montpellier approved this study (REC number: 202100733).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"KSL.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}}]}}